Drawing for MILLICENT PHARMA

USPTO serial 79273599

MILLICENT PHARMA

Reviewed by CopyMark Law Group

Reg. 6187257Status 700Renewal
Filing date
Status date
Registration date
Nov 3, 2020
Examiner
CASE, LEIGH CAROLINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MILLICENT PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristen S. Ruisi

Kristen S. Ruisi Venable LLP151 West 42nd Street, 49th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredients for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemicals additives for use in the manufacture of pharmaceuticals in the pharmaceutical industry; chemicals for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical additives for use in the manufacture of pharmaceuticalsACTIVE—
005Pharmaceutical and veterinary preparations for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical and veterinary preparations, namely contraceptive preparations and substances; sanitary preparations for medical purposes; sterilizing preparations; hormone replacement therapy preparations; dietetic foods adapted for medical or veterinary use; dietetic substances, namely dietetic sugar and sugar substitutes for medical use, dietetic infusions for medical use, dietetic preparations for medical purposes, dietetic beverages for medical purposes; food for babies; medicated supplements for foodstuffs for babies; dietary supplements for humans and animals; plasters for medical purposes; materials for dressings, namely, bandages for dressings, gauze for dressings, wadding for dressings, and transparent film for dressings; material for stopping teeth, dental wax; dietary supplements for humans and dietetic preparations adapted for medical purposes, and dietary supplements for animals; dental preparations, namely, dental preparations for disclosing plaque and tartar on the teeth, anti-cavity dental coating preparations containing fluoride, dental varnish for use by dentists, dental compounds used in endodontic procedures, dental abrasives; dental articles, namely, prefilled dental trays for applying dental compositions to teeth, materials for making dental impressions, materials for dental use for fillings, material for dental crowns, material for dental bridges, amalgam for dental purposes, dental sealants, dental resin cement, dental hemostatic paste, dental adhesives, medicated dental rinses, dental blanks, bonding and primer materials for dental purposes, dental polish, dental veneers for use in dental restoration; anesthetics; analgesics; bone cement for surgical and orthopedic purposes; capsules for medicines, namely, capsules sold empty for pharmaceuticals, decongestant capsules, allergy capsules; medical and veterinary preparations for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders and articles, namely, enzyme preparations for medical purposes and surgical implants comprised of living tissue, diagnostic preparations for medical purposes, pharmaceuticals, namely, for use in the prevention treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, and natural remedies, namely, natural remedy preparation for the prevention and treatment for the treatment viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, medical dressings, medical coverings for dressings used to cover and treat wounds and burns and medical applicators for the treatment of wounds and burns; hygienic preparations and articles, namely, disinfectants for hygiene purposes and antiseptics, all-purpose deodorizers preparations for household, commercial and industrial use and air purifiers preparations, absorbent articles for personal hygiene, namely, pants, sanitary pads and absorbents for incontinence; disinfectants; preparations for destroying vermin; fungicides, herbicides; pest control preparations, namely, insecticides and poisons for domestic and agricultural use, and articles, namely, freeze dried food bait for pest control purposes, granular repellent for burrowing pests; drug delivery agents in the form of tablets, capsules, suppositories, dissolvable films, coatings for tablets, compounds, edible wafers for wrapping powdered pharmaceuticals that facilitate the deferred, controlled or immediate release of active substances of pharmaceutical preparationsACTIVE—
010Surgical apparatus and instruments; medical apparatus and instruments for use in surgery and for use in the prevention, monitoring and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dental apparatus and instruments, namely, dental drills, dental drill bits, milling apparatus for dental purposes, dental root files, sprayers for cleaning teeth and gums, oral irrigators, dental clips, bite trays, dental impression trays, prophy angles, apex locators, intra-oral dental light systems, dental picks, dental operating lamps, prosthetic instruments for dental purposes, hemostats, forceps for dental technical purposes, implant bridges and abutments for dental purposes and teeth protectors; Orthodontic machines and instruments for dental purposes; veterinary apparatus and instruments, for use in surgery of animals and for use in the prevention, monitoring and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders in animals; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic joint implants made of artificial materials, external orthopedic devices using electrical signals to stimulate bone growth, orthopedic knee bandages, joint prosthesis, bone prosthesis, orthopedic walkers, orthopedic cushions and padding, orthopedic soles, orthopedic footwear, orthopedic supports and orthopedic belts and braces; bracelets for medical purposes; suture materials; blood testing apparatus; diagnostic apparatus for medical purposes used in the testing, monitoring and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical products, namely, intravaginal drug delivery device for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; medical products, namely, implantable subcutaneous drug delivery devices for hormone replacement therapy products; medical products, namely, intravaginal drug delivery devices for hormone replacement therapy products; intra vaginal ring for delivery of hormone replacement therapy products by a continuous release system; inhalers for medical use; physical therapy equipment, in the nature of massage apparatus, physiotherapy and rehabilitation equipment designed specifically for medical use, namely, force and motion testing apparatus, shoulder stretcher using resistance cables, stretching machines and devices for therapeutic purposes, and body rehabilitation apparatus for medical purposes; hearing protection devices, namely, hearing protectors without the ability to reproduce or transmit sound; feeding aids, namely, disposable teats being pacifiers for babies and pacifiers for babies; contraceptive devices, namely, condoms, intra-uterine contraceptive devices, diaphragms for contraception and medical implants for contraceptive purposes; syringes for injections and for medical purposes; medical apparatus, namely, medical syringes and medical measuring apparatus, being those that can directly transmit data to a database, particularly thermometers for medical use, pulse meters and medical apparatus for measuring respiratory rates and sleeping conditions; prosthetics limbs, namely arms, feet, legs and artificial implants, namely, surgical implants consisting primarily of artificial materials and also including biological material, hearing aids, dental prostheses; orthopedic aids, namely, footwear, soles, insoles, knee bandages, braces, belts and mobility aids, namely, walkers and wheeled walkers to aid in mobility; with parts and fittings of all the aforesaid goodsACTIVE—
042Medical research services in the field of or for use in the field of the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders and pharmacological research services; scientific and technological research services relating to viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 29, 2026ES71TEAS SECTION 71 RECEIVED—
Aug 18, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 18, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 18, 2026EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Aug 18, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 3, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 10, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 10, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 10, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 7, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 17, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 17, 2021FIMPFINAL DISPOSITION PROCESSED—
Feb 3, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 3, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 18, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 18, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 16, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 10, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 10, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 10, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 5, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 5, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 5, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 5, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 5, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 5, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 1, 2020RFNTREFUSAL PROCESSED BY IB—
Jan 13, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 13, 2020RFRRREFUSAL PROCESSED BY MPU—
Jan 7, 2020DOCKASSIGNED TO EXAMINER—
Dec 14, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 13, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 12, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2019DOCKASSIGNED TO EXAMINER—
Dec 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance